Aaron Ondrey

Aaron Ondrey

No más puestos en curso

Fortuna: 393 491 $ al 31/05/2026

50 años
Health Technology
Consumer Services

Perfil

Aaron Ondrey formerly worked at Regeneron Pharmaceuticals, Inc., as Executive Director-Commercial Finance from 2010 to 2018, Mirati Therapeutics, Inc., as Chief Financial Officer & SVP-Financial Planning from 2023 to 2024, Rocket Pharmaceuticals, Inc., as Chief Financial Officer from 2024 to 2025, Alexion Pharmaceuticals, Inc., as Head-US & Global Commercial Finance, and Arena Pharmaceuticals, Inc., as Vice President-Finance.
Mr. Ondrey received his undergraduate degree from Case Western Reserve University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
03/07/2025 128.173 ( 0,12 % ) 393 491 $ 31/05/2026

Antiguos cargos conocidos de Aaron Ondrey.

EmpresasCargoFin
ROCKET PHARMACEUTICALS, INC. Director Financiero/CFO 05/09/2025
MIRATI THERAPEUTICS Director Financiero/CFO 23/01/2024
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2018
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal -
ARENA PHARMACEUTICALS Director Financiero/CFO -
Ver el detalle de la experiencia de Aaron Ondrey.

Formación de Aaron Ondrey.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

36

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology